Titan Medical Announces Change to Presentation Time at H.C. Wainwright Conference

Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD) (Nasdaq: TMDI), a medical device company focused on the design, development and commercialization of a robotic surgical system for application in minimally invasive surgery (“MIS”), announces that management’s presentation at the H.C. Wainwright 21st Annual Global Investment Conference has been moved to 2:35 p.m. Eastern time on Tuesday, September 10. The presentation had previously been scheduled for 4:15 p.m. Eastern time that day. Management’s presentation will be webcast live and a replay will be available on the Investor Relations portion of the Company’s website.

About Titan Medical Inc.

Titan Medical Inc. is focused on computer-assisted robotic surgical technologies for application in MIS. The Company is developing a single-port robotic surgical system comprised of a surgeon-controlled patient cart that includes a 3D high-definition vision system and multi-articulating instruments for performing MIS procedures, and a surgeon workstation that provides an advanced ergonomic interface to the patient cart and a 3D endoscopic view inside the patient’s body. Titan intends to initially pursue gynecologic surgical indications for use of its single-port robotic surgical system.

For more information, please visit the Company’s website at www.titanmedicalinc.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20190906005226/en/

LHA Investor Relations
Kim Sutton Golodetz
(212) 838-3777
[email protected]
or
Bruce Voss
(310) 691-7100
[email protected]